Patents matching “monoclonal”

US 7700738

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Apr 20, 2010 · Expires Apr 15, 2030

WO 2010030203

ANTICORPS MONOCLONAL DIRIGÉ CONTRE LA TRANSTHYRÉTINE HUMAINE AMYLOÏDOGÈNE ET DES FORMES MODIFIÉES DE CELLE-CI ET SON UTILISATION DANS LA DÉTECTION ET LE TRAITEMENT DE LA FAP ET DE PATHOLOGIES PRÉSENTANT UNE TTR MODIFIÉE

BIOCODEX INCUBACAO DE EMPRESAS [PT] · Granted Mar 18, 2010 · Expires Mar 13, 2030

US 7658923

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26

The Board of Regents of the University of Texas System · Granted Feb 9, 2010 · Expires Feb 4, 2030

US 7655762

Monoclonal antibodies against ANGPTL4

LEXICON PHARMACEUTICALS, INC. · Granted Feb 2, 2010 · Expires Jan 28, 2030

US 7622113

Monoclonal antibodies that bind or neutralize dengue virus

The United States of America, as represented by the Department of Health and Human Services · Granted Nov 24, 2009 · Expires Nov 19, 2029

US 7566540

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Jul 28, 2009 · Expires Jul 23, 2029

US 7563874

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Jul 21, 2009 · Expires Jul 16, 2029

US 7501494

Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

United Biomedical, Inc. · Granted Mar 10, 2009 · Expires Mar 5, 2029

US 7459536

HGF-SF monoclonal antibody combinations

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 2, 2008 · Expires Nov 27, 2028

US 7335356

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein

The United States of America as represented by the Secretary of the Army · Granted Feb 26, 2008 · Expires Feb 21, 2028

US 7256004

Variants of humanized anti-carcinoma monoclonal antibody CC49

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 14, 2007 · Expires Aug 9, 2027

US 7198788

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.

The Board of Regents of the University of Texas System · Granted Apr 3, 2007 · Expires Mar 29, 2027

US 7183389

Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)

Molecular Discoveries, Inc. · Granted Feb 27, 2007 · Expires Feb 22, 2027

US 7175845

Monoclonal antibodies against ricin toxin and methods of making and using thereof

The United States of America as represented by the Secretary of the Army · Granted Feb 13, 2007 · Expires Feb 8, 2027

US 7105643

Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates

The United States of America as represented by the Attorney General of the Dept. of Justice · Granted Sep 12, 2006 · Expires Sep 7, 2026

US 7094883

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 6924362

Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 2, 2005 · Expires Jul 28, 2025

US 6875433

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein

The United States of America as represented by the Secretary of the Army · Granted Apr 5, 2005 · Expires Mar 31, 2025

US 6818749

Variants of humanized anti carcinoma monoclonal antibody cc49

The United States of America, as represented by the Department of Health and Human Services · Granted Nov 16, 2004 · Expires Nov 11, 2024

US 6689362

Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)

Regents of the University of Minnesota · Granted Feb 10, 2004 · Expires Feb 5, 2024

US 6630144

Monoclonal antibodies to Ebola glycoprotein

The United States of America as represented by the Secretary of the Army · Granted Oct 7, 2003 · Expires Oct 2, 2023

US 6620412

Prophylactic and therapeutic monoclonal antibodies

The United States of America as represented by the Secretary of the Army · Granted Sep 16, 2003 · Expires Sep 11, 2023

US 6551599

Monoclonal antibodies against campylobacter jejuni and campylobacter coli outer membrane antigens

The United States of America, as represented by the Secretary of Agriculture · Granted Apr 22, 2003 · Expires Apr 17, 2023

US 6506885

Monoclonal antibodies to the drug tilmicosin and a method for detecting the same

The United States of America, as represented by the Secretary of Agriculture · Granted Jan 14, 2003 · Expires Jan 9, 2023